|
Originally published In Press as doi:10.1074/jbc.M609695200 on February 5, 2007
J. Biol. Chem., Vol. 282, Issue 14, 10576-10584, April 6, 2007
Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway*
Lily I. Jiang 1,
Julie Collins ,
Richard Davis ,
Keng-Mean Lin ,
Dianne DeCamp ,
Tamara Roach ,
Robert Hsueh ,
Robert A. Rebres ,
Elliott M. Ross ,
Ronald Taussig ,
Iain Fraser¶, and
Paul C. Sternweis 2
From the
Department of Pharmacology, Alliance for Cellular Signaling, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9196, the Veterans Administration Medical Center, University of California, San Francisco, California 94121, and the ¶Division of Biology, California Institute of Technology, Pasadena, California 91125
Regulation of intracellular cyclic adenosine 3 ',5 '-monophosphate (cAMP) is integral in mediating cell growth, cell differentiation, and immune responses in hematopoietic cells. To facilitate studies of cAMP regulation we developed a BRET (bioluminescence resonance energy transfer) sensor for cAMP, CAMYEL (cAMP sensor using YFP-Epac-RLuc), which can quantitatively and rapidly monitor intracellular concentrations of cAMP in vivo. This sensor was used to characterize three distinct pathways for modulation of cAMP synthesis stimulated by presumed Gs-dependent receptors for isoproterenol and prostaglandin E2. Whereas two ligands, uridine 5 '-diphosphate and complement C5a, appear to use known mechanisms for augmentation of cAMP via Gq/calcium and Gi, the action of sphingosine 1-phosphate (S1P) is novel. In these cells, S1P, a biologically active lysophospholipid, greatly enhances increases in intracellular cAMP triggered by the ligands for Gs-coupled receptors while having only a minimal effect by itself. The enhancement of cAMP by S1P is resistant to pertussis toxin and independent of intracellular calcium. Studies with RNAi and chemical perturbations demonstrate that the effect of S1P is mediated by the S1P2 receptor and the heterotrimeric G13 protein. Thus in these macrophage cells, all four major classes of G proteins can regulate intracellular cAMP.
Received for publication, October 16, 2006
, and in revised form, January 29, 2007.
* This work was supported by National Institutes of Health Grant GM 62114, the Robert A. Welch foundation (to P. C. S.), and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental data and Figs. S1-S7.
1 To whom correspondence may be addressed: UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9196. Tel.: 214-645-6105; Fax: 214-645-6118; E-mail: lily.jiang{at}utsouthwestern.edu.
2 To whom correspondence may be addressed: UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9196. Tel.: 214-645-6149; Fax: 214-645-6118; E-mail: paul.sternweis{at}utsouthwestern.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. C. Hsueh, M. Natarajan, I. Fraser, B. Pond, J. Liu, S. Mumby, H. Han, L. I. Jiang, M. I. Simon, R. Taussig, et al.
Deciphering Signaling Outcomes from a System of Complex Networks
Sci. Signal.,
May 19, 2009;
2(71):
ra22 - ra22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Skoura and T. Hla
Regulation of vascular physiology and pathology by the S1P2 receptor subtype
Cardiovasc Res,
May 1, 2009;
82(2):
221 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Barak, A. Salahpour, X. Zhang, B. Masri, T. D. Sotnikova, A. J. Ramsey, J. D. Violin, R. J. Lefkowitz, M. G. Caron, and R. R. Gainetdinov
Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor
Mol. Pharmacol.,
September 1, 2008;
74(3):
585 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Rasko, C. G. Moreira, D. R. Li, N. C. Reading, J. M. Ritchie, M. K. Waldor, N. Williams, R. Taussig, S. Wei, M. Roth, et al.
Targeting QseC Signaling and Virulence for Antibiotic Development
Science,
August 22, 2008;
321(5892):
1078 - 1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. I. Jiang, J. Collins, R. Davis, I. D. Fraser, and P. C. Sternweis
Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VII
J. Biol. Chem.,
August 22, 2008;
283(34):
23429 - 23439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Iancu, G. Ramamurthy, S. Warrier, V. O. Nikolaev, M. J. Lohse, S. W. Jones, and R. D. Harvey
Cytoplasmic cAMP concentrations in intact cardiac myocytes
Am J Physiol Cell Physiol,
August 1, 2008;
295(2):
C414 - C422.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|